Naether O, Diedrich K
Geburtshilfe Frauenheilkd. 1992 Feb;52(2):121-2. doi: 10.1055/s-2007-1022966.
GnRH analogues are widely used for the reduction of uterine fibroids. This case report describes the therapy of a 27-year-old woman, whose uterus had a diameter of about 13 cm. After 7 injections of Zoladex Depot (ICI Pharma, Heidelberg, Germany), the uterus was reduced to normal size carrying dorsally a myoma of the same size. After only 7 weeks of medroxyprogesterone acetate (5 mg twice daily, Clinofem, Upjohn, Heppenheim, Germany) the uterus had grown again, so that therapy was changed to Zoladex Depot for another 3 months. On the 27th day of the first spontaneous cycle, the patient ovulated and conceived. Up to the 29th week of gestation (Aug '91), the foetal growth and development was normal, the uterus was normal in size, a childhead sized myoma being situated unproblematically behind the foetus.
促性腺激素释放激素类似物被广泛用于缩小子宫肌瘤。本病例报告描述了一名27岁女性的治疗情况,其子宫直径约为13厘米。在注射7次长效诺雷德(德国海德堡ICI制药公司生产)后,子宫缩小至正常大小,子宫背侧有一个大小相同的肌瘤。仅服用醋酸甲羟孕酮(每日两次,每次5毫克,德国黑彭海姆Upjohn公司生产的克龄蒙)7周后,子宫又增大了,因此治疗改为再次使用长效诺雷德3个月。在第一个自然周期的第27天,患者排卵并受孕。直至妊娠第29周(1991年8月),胎儿生长发育正常,子宫大小正常,一个胎头大小的肌瘤位于胎儿后方,未出现问题。